Potential ASCO Practice-Changers in HER2+ Breast Cancer

Oncologists will debate the APHINITY trial data for years to come, says Dr Kevin Kalinsky.

Source: Medscape Oncology - July 7, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts